And turning to the financial details for the Q2. Consolidated net operating income was $3,100,000 as compared to 3.6 1,000,000 in the Q2 of 2022. Net income was $2,800,000 or 0 point 0 $7 per diluted share compared to net income of 2.6 1,000,000 or $0.07 per diluted share in the Q2 of 2022. EBITDA was $3,200,000 as compared to EBITDA of $3,800,000 in the Q2 of 2022 and adjusted EBITDA was $3,500,000 for the Q2 of 2023 as compared to $3,900,000 in the Q2 of 2022. Our balance sheet remains strong with stock holders' equity of $54,200,000 as of June 30, 2023 compared to $48,300,000 as of December 31, 2022 And net working capital of $15,500,000 Additionally, our total balance related to investments in loans to Buyers of charge off and non performing receivable portfolios was $29,900,000 as of June 30, 2023, of which $15,000,000 is classified as notes receivable and $14,900,000 is classified as equity method investments.